Values First Advisors, Inc. Annexon, Inc. Transaction History

Values First Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 02, 2023	SELL	$2.1 - $6.37 $12,362 - $37,500	-5,887 Reduced 32.35%	12,309 $43,000
Q1 2023 May 15, 2023	BUY	$3.74 - $7.46 $3,728 - $7,437	997 Added 5.8%	18,196 $70,000
Q4 2022 Jan 20, 2023	SELL	$4.56 - $6.61 $19,981 - $28,965	-4,382 Reduced 20.3%	17,199 $0
Q3 2022 Dec 02, 2022	BUY	$3.75 - $6.63 $80,928 - $143,082	21,581 New	21,581 $133,000
Q2 2022 Jul 20, 2022	SELL	$2.11 - $4.06 $25,187 - $48,464	-11,937 Closed	0 $0
Q1 2022 May 03, 2022	BUY	$2.73 - $11.94 $32,588 - $142,527	11,937 New	11,937 $33,000

156

101M

3.73M

1.3M

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $335M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

Get notified when there are updates to the investment portfolio of Values First Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Values First Advisors, Inc. with notifications on news.